Synthesis and in vitro drug release studies on substituted polyphosphazene conjugates of lumefantrine.

<p class="Default"><span>The present study pertains to the delivery of antimalarial drug (Lumifantrine). In this, polyphosphazene has been used in the synthesis of polyphosphazene-linked conjugates of Lumifantrine. These polymer-linked Conjugates have been synthesized and characterized by modern analytical techniques. The <em>in-vitro</em> drug release of Lumifantrine drug conjugates: <em>p</em>-Amino benzoic acid ester substituted polyphosphazene drug conjugate <strong>(15)</strong> and Glycine methyl ester substituted polyphosphazene drug conjugate <strong>(21) </strong>have been found to be 6.00 % and 5.96% (pH 1.2), 88.52% and 79.86% (pH 7.4), respectively. These drug conjugate may prove an effective delivery system for the treatment of malaria.</span></p>

Kinetics of base hydrolysis of α-amino acid esters catalyzed by palladium(II) piperazine complex

The kinetics of base hydrolysis of glycine, histidine, and methionine methyl esters in the presence of [Pd(pip)(H2O)2]2+ complex, where pip is piperazine, is studied in aqueous solutions, at T = 25°C, and I = 0.1 mol dm−3. The rate of ester hydrolysis for glycine methyl ester is studied at different temperature and dioxane/water solutions of different compositions. The kinetic data are fit under the assumption that the hydrolysis proceeds in one step. The activation parameters for the base hydrolysis of the complexes are evaluated